Seemal R. Desai, MD, FAAD, is a diplomate of the American Board of Dermatology and a board-certified dermatologist. He graduated with honors from Emory University. He received his medical training at Morehouse School of Medicine in Atlanta, Georgi...
Seemal R. Desai, MD, FAAD, is a diplomate of the American Board of Dermatology and a board-certified dermatologist. He graduated with honors from Emory University. He received his medical training at Morehouse School of Medicine in Atlanta, Georgia, and received his doctor of medicine degree magna cum laude with honors.
Following medical school, Dr. Desai completed his medical internship in internal medicine. He then went on to complete his residency at the University of Alabama at Birmingham and served as chief resident for the Department of Dermatology.
Dr. Desai has been active on local, state, and national levels with numerous medical organizations. His major accomplishments have been with the American Academy of Dermatology and the American Medical Association, where he has held numerous elected and appointed positions. He is also actively involved in teaching and mentoring medical students and residents. He currently serves as clinical assistant professor of dermatology at the University of Texas Southwestern Medical Center.
Dr. Desai is the author of numerous publications and has been invited to present at numerous international dermatology events. He is a world-renowned expert on the treatment of vitiligo and other disorders of pigmentation, psoriasis, acne, cosmeceuticals and phototherapy.
Dr. Desai is very active in the local and national dermatologic communities. He is the immediate past president of the Skin of Color Society and immediate past president of the Texas Dermatological Society. In addition, he is a past president of the Dallas/Fort Worth Dermatological Society. He has also served on the board of directors of SkinPAC and currently is on the AAD Congressional Policy Committee. He is also immediate past chair of the AAD Leadership Development Steering Committee. Dr. Desai was elected to the AAD board of directors and represents the interests of more than 20,000 dermatologists worldwide. Dr. Desai was also appointed to serve on the US Food & Drug Administration’s Pharmacy Compounding Advisory Committee and is the only dermatologist on this important hearing committee. He also serves as the associate editor of the Journal of Clinical and Aesthetic Dermatology and Pigment International, while also serving on numerous editorial advisory boards.